AGL 38.89 Increased By ▲ 0.87 (2.29%)
AIRLINK 206.39 Increased By ▲ 9.03 (4.58%)
BOP 9.64 Increased By ▲ 0.10 (1.05%)
CNERGY 6.30 Increased By ▲ 0.39 (6.6%)
DCL 9.10 Increased By ▲ 0.28 (3.17%)
DFML 37.85 Increased By ▲ 2.11 (5.9%)
DGKC 98.10 Increased By ▲ 1.24 (1.28%)
FCCL 35.72 Increased By ▲ 0.47 (1.33%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.85 Increased By ▲ 0.68 (5.16%)
HUBC 130.00 Increased By ▲ 2.45 (1.92%)
HUMNL 13.61 Increased By ▲ 0.11 (0.81%)
KEL 5.48 Increased By ▲ 0.16 (3.01%)
KOSM 7.31 Increased By ▲ 0.31 (4.43%)
MLCF 44.95 Increased By ▲ 0.25 (0.56%)
NBP 60.75 Decreased By ▼ -0.67 (-1.09%)
OGDC 221.00 Increased By ▲ 6.33 (2.95%)
PAEL 40.95 Increased By ▲ 2.16 (5.57%)
PIBTL 8.52 Increased By ▲ 0.27 (3.27%)
PPL 199.00 Increased By ▲ 5.92 (3.07%)
PRL 39.80 Increased By ▲ 1.14 (2.95%)
PTC 27.32 Increased By ▲ 1.52 (5.89%)
SEARL 108.05 Increased By ▲ 4.45 (4.3%)
TELE 8.61 Increased By ▲ 0.31 (3.73%)
TOMCL 36.05 Increased By ▲ 1.05 (3%)
TPLP 13.76 Increased By ▲ 0.46 (3.46%)
TREET 24.38 Increased By ▲ 2.22 (10.02%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 33.23 Increased By ▲ 0.26 (0.79%)
WTL 1.68 Increased By ▲ 0.08 (5%)
BR100 11,996 Increased By 269.5 (2.3%)
BR30 37,173 Increased By 796.8 (2.19%)
KSE100 112,475 Increased By 2961.9 (2.7%)
KSE30 35,481 Increased By 968.1 (2.8%)

BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test and they could deliver an Omicron-based vaccine in March 2022 if needed.

In the first official statement from vaccine manufacturers on the likely efficacy of their shot against Omicron, BioNTech and Pfizer said that two vaccine doses resulted in significantly lower neutralising antibodies but that a third dose of their vaccine increased the neutralising antibodies by a factor of 25.

Blood obtained from people that had their third booster shot a month ago neutralised the Omicron variant about as effectively as blood after two doses fought off the original virus first found in China. "Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19" Pfizer boss Albert Bourla said in the statement.

UK issues call to arms for Omicron booster drive

The findings are broadly in line with a preliminary study

published by researchers at the Africa Health Research Institute in South Africa on Tuesday, saying that Omicron can partially evade protection from two doses of the Pfizer/BioNTech vaccine, suggesting also that a third shot might help fend off infection.

A lab analysis at the university hospital of Frankfurt, Germany, however found a reduced antibody response to Omicron even after three shots.

Omicron variant found in almost one-third of US states

Comments

Comments are closed.